Boardroom Alpha
Boardroom Alpha
FMNB · Current Report (Form 8-K) · Filed April 16, 2026

Farmers National Banc Corp — Current Report (Form 8-K)

Form
8-K
Filed
April 16, 2026
Period
Apr 16, 2026
Ticker
FMNB
Accession
0001437749-26-012568
Boardroom Alpha · Filing insights

Shareholders approved the 2026 Equity Incentive Plan and elected four Class I directors.

About Farmers National Banc Corp
Market cap
$844M
1Y TSR
+10.8%
3Y TSR
+9.0%
Board grade
C
Sector
Financial Services
CEO
Kevin J Helmick
Last annual meeting: Apr 16, 2026 · View full Farmers National Banc Corp profile →
fmnb20260416_8k.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): April 16, 2026
 
Farmers National Banc Corp.

(Exact name of registrant as specified in its charter)
 
Ohio 001-35296 34-1371693
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
 
20 South Broad Street, P.O. Box 555, Canfield, Ohio 44406-0555
(Address of principal executive offices) (Zip Code)
 
(330) 533-3341

(Registrant’s telephone number, including area code)
 
 

(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class   Trading Symbol   Name of each exchange on which registered
Common Stock, No Par Value   FMNB   The NASDAQ Stock Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 5.02        Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On April 16, 2026, at the 2026 Annual Meeting of Shareholders (the “2026 Annual Meeting”) of Farmers National Banc Corp. (the “Company”), the shareholders of the Company approved the Company’s 2026 Equity Incentive Plan (the “Plan”). The Board of Directors of the Company previously adopted the Plan on February 24, 2026, subject to shareholder approval. Under the Plan, the Company may grant equity-based incentive awards to non-employee directors, officers, and other eligible participants. A total of 1,000,000 shares of the Company’s common stock are reserved for issuance under the Plan. The awards available for grant under the Plan include restricted stock, stock units and share awards. The Plan will be administered by the Compensation Committee of the Board of Directors.
 
The foregoing summary of the Plan is qualified in its entirety by reference to the detailed summary of the Plan set forth in the section “Proposal Four — Adoption and Approval of the Farmers National Banc Corp. 2026 Equity Incentive Plan” in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on March 16, 2026 and to the full text of the Plan, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
 
Item 5.07        Submission of Matters to a Vote of Security Holders.
 
On April 16, 2026, the Company held the 2026 Annual Meeting for the purposes of: (1) electing four Class I directors to each serve for a term of three years to expire at the Annual Meeting of Shareholders to be held in 2029; (2) considering and voting upon a non-binding advisory resolution to approve the compensation of the Company’s named executive officers; (3) considering and voting upon a proposal to ratify the appointment of Crowe LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026; and (4) considering and voting upon a proposal to approve the adoption of the Plan. As of the close of business on February 25, 2026, the record date for the 2026 Annual Meeting, 37,738,759 common shares were outstanding and entitled to vote. At the Annual Meeting, 29,654,001 or approximately 78.58%, of the outstanding common shares entitled to vote were represented in person or by proxy, including 6,608,999 broker non-votes. The results of the voting at the 2026 Annual Meeting are as follows:
 
Proposal 1: The Company’s shareholders elected the following nominees for director to serve a three-year term ending at the 2029 Annual Meeting of Shareholders:
 
Name
Votes For
Votes Withheld
Broker Non-Votes
Gregory C. Bestic
20,337,411
2,707,591
6,608,999
Kevin J. Helmick
20,667,467
2,377,535
6,608,999
Neil J. Kaback
20,764,097
2,280,905
6,608,999
Terry A. Moore
19,410,468
3,634,533
6,608,999
 
Proposal 2: The Company’s shareholders approved an advisory resolution to approve the 2025 compensation paid to the Company’s named executive officers, with 85.28% of shares voted being cast in favor of the proposal:
 
Votes For
Votes Against
Abstentions
Broker Non-Votes
19,651,675
2,837,970
555,356
6,608,999
 
Proposal 3: The Company’s shareholders ratified the appointment of Crowe LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026:
 
Votes For
Votes Against
Abstentions
Broker Non-Votes
29,426,210
119,658
106,458
0
 
Proposal 4: The Company’s shareholders approved the adoption of the Farmers National Banc Corp. 2026 Equity Incentive Plan:
 
Votes For
Votes Against
Abstentions
Broker Non-Votes
19,530,286
3,005,759
508,956
6,608,999
 
Item 9.01
         
Financial Statements and Exhibits.
 
 
(d)          Exhibits.
 
Exhibit Number
Description
10.1
Farmers National Banc Corp. 2026 Equity Incentive Plan
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Farmers National Banc Corp.
 
By: /s/ Kevin J. Helmick
Kevin J. Helmick
President and Chief Executive Officer
 
 
Date: April 16, 2026
 
 
 
 
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Farmers National Banc Corp (FMNB)

Reference

Frequently asked questions

When did Farmers National Banc Corp file this 8-K?
Farmers National Banc Corp (FMNB) filed this Current Report (Form 8-K) with the SEC on April 16, 2026. The accession number assigned by EDGAR is 0001437749-26-012568.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Shareholders approved the 2026 Equity Incentive Plan and elected four Class I directors. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Farmers National Banc Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Farmers National Banc Corp has filed under CIK 709337, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer